In this report, the study analysis was given on a worldwide scale, for instance, present and traditional Clinical Next-Generation Sequencinggrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of sales, revenue and price.
According to XYZResearch, the global Clinical Next-Generation Sequencing market was valued at USD xxx million in 2019, and it is expected to reach a value of USD xxx million by 2026, at a CAGR of xx% over the forecast period 2021-2026. Correspondingly, the forecast analysis of Clinical Next-Generation Sequencing industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the sales and revenue data in each of the sub-segments.
At the upcoming section, this report discusses industrial policy, economic environment, in addition to the fabrication processes and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Clinical Next-Generation Sequencing in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Clinical Next-Generation Sequencing market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Roche
Pacific Bioscience
Agilent Technologies
Macrogen
Oxford Nanopore
Foundation Medicine
Life technologies
Exosome Diagnostics
CLC Bio
Paradigm
Partek
GnuBIO
Caris Life Sciences
Others
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Targeted Sequencing
Exome Sequencing
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Clinical Next-Generation Sequencing for each application, including
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Clinical Next-Generation Sequencing Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Clinical Next-Generation Sequencing Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Targeted Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Exome Sequencing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Clinical Next-Generation Sequencing Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Clinical Next-Generation Sequencing Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Clinical Next-Generation Sequencing Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Clinical Next-Generation Sequencing Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Clinical Next-Generation Sequencing Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Clinical Next-Generation Sequencing Market Assessment by Type
8.1 Asia Pacific Clinical Next-Generation Sequencing Market Assessment by Application (Consumption and Market Share)
8.2 North America Clinical Next-Generation Sequencing Market Assessment by Application (Consumption and Market Share)
8.3 Europe Clinical Next-Generation Sequencing Market Assessment by Application (Consumption and Market Share)
8.4 South America Clinical Next-Generation Sequencing Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Clinical Next-Generation Sequencing Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Profiles
9.1.2 Thermo Fisher Scientific Product Portfolio
9.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Performance
9.1.4 Thermo Fisher Scientific Clinical Next-Generation Sequencing Business Development and Market Status
9.2 PerkinElmer
9.2.1 PerkinElmer Profiles
9.2.2 PerkinElmer Product Portfolio
9.2.3 PerkinElmer Clinical Next-Generation Sequencing Business Performance
9.2.4 PerkinElmer Clinical Next-Generation Sequencing Business Development and Market Status
9.3 Illumina
9.3.1 Illumina Profiles
9.3.2 Illumina Product Portfolio
9.3.3 Illumina Clinical Next-Generation Sequencing Business Performance
9.3.4 Illumina Clinical Next-Generation Sequencing Business Development and Market Status
9.4 Beckman Coulter
9.4.1 Beckman Coulter Profiles
9.4.2 Beckman Coulter Product Portfolio
9.4.3 Beckman Coulter Clinical Next-Generation Sequencing Business Performance
9.4.4 Beckman Coulter Clinical Next-Generation Sequencing Business Development and Market Status
9.5 GATC Biotech
9.5.1 GATC Biotech Profiles
9.5.2 GATC Biotech Product Portfolio
9.5.3 GATC Biotech Clinical Next-Generation Sequencing Business Performance
9.5.4 GATC Biotech Clinical Next-Generation Sequencing Business Development and Market Status
9.6 Qiagen
9.6.1 Qiagen Profiles
9.6.2 Qiagen Product Portfolio
9.6.3 Qiagen Clinical Next-Generation Sequencing Business Performance
9.6.4 Qiagen Clinical Next-Generation Sequencing Business Development and Market Status
9.7 Roche
9.7.1 Roche Profiles
9.7.2 Roche Product Portfolio
9.7.3 Roche Clinical Next-Generation Sequencing Business Performance
9.7.4 Roche Clinical Next-Generation Sequencing Business Development and Market Status
9.8 Pacific Bioscience
9.8.1 Pacific Bioscience Profiles
9.8.2 Pacific Bioscience Product Portfolio
9.8.3 Pacific Bioscience Clinical Next-Generation Sequencing Business Performance
9.8.4 Pacific Bioscience Clinical Next-Generation Sequencing Business Development and Market Status
9.9 Agilent Technologies
9.9.1 Agilent Technologies Profiles
9.9.2 Agilent Technologies Product Portfolio
9.9.3 Agilent Technologies Clinical Next-Generation Sequencing Business Performance
9.9.4 Agilent Technologies Clinical Next-Generation Sequencing Business Development and Market Status
9.10 Macrogen
9.10.1 Macrogen Profiles
9.10.2 Macrogen Product Portfolio
9.10.3 Macrogen Clinical Next-Generation Sequencing Business Performance
9.10.4 Macrogen Clinical Next-Generation Sequencing Business Development and Market Status
9.11 Oxford Nanopore
9.12 Foundation Medicine
9.13 Life technologies
9.14 Exosome Diagnostics
9.15 CLC Bio
9.16 Paradigm
9.17 Partek
9.18 GnuBIO
9.19 Caris Life Sciences
9.20 Others
10 World Clinical Next-Generation Sequencing Market Assessment by Players
10.1 Global Clinical Next-Generation Sequencing Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Clinical Next-Generation Sequencing Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Clinical Next-Generation Sequencing Price (USD/Unit) of Players 2014-2020
10.4 Global Clinical Next-Generation Sequencing Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Clinical Next-Generation Sequencing Sales Assessment of Players 2014-2020
11.1.2 North America Clinical Next-Generation Sequencing Revenue Assessment of Players 2014-2020
11.1.3 North America Clinical Next-Generation Sequencing Price Assessment of Players 2014-2020
11.1.4 North America Clinical Next-Generation Sequencing Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Clinical Next-Generation Sequencing Sales Assessment of Players 2014-2020
11.2.2 Europe Clinical Next-Generation Sequencing Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Clinical Next-Generation Sequencing Price Assessment of Players 2014-2020
11.2.4 Europe Clinical Next-Generation Sequencing Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Clinical Next-Generation Sequencing Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Clinical Next-Generation Sequencing Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Clinical Next-Generation Sequencing Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Clinical Next-Generation Sequencing Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Clinical Next-Generation Sequencing Sales Assessment of Players 2014-2020
11.4.2 South America Clinical Next-Generation Sequencing Revenue Assessment of Players 2014-2020
11.4.3 South America Clinical Next-Generation Sequencing Price Assessment of Players 2014-2020
11.4.4 South America Clinical Next-Generation Sequencing Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Clinical Next-Generation Sequencing Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Clinical Next-Generation Sequencing Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Clinical Next-Generation Sequencing Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Clinical Next-Generation Sequencing Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Clinical Next-Generation Sequencing Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Clinical Next-Generation Sequencing Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Clinical Next-Generation Sequencing Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Clinical Next-Generation Sequencing Sales by Countries/Regions 2014-2020
12.2.2 North America Clinical Next-Generation Sequencing Revenue by Countries/Regions 2014-2020
12.2.3 North America Clinical Next-Generation Sequencing Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Clinical Next-Generation Sequencing Sales by Countries/Regions 2014-2020
12.3.2 Europe Clinical Next-Generation Sequencing Revenue by Countries/Regions 2014-2020
12.3.3 Europe Clinical Next-Generation Sequencing Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Clinical Next-Generation Sequencing Sales by Countries/Regions 2014-2020
12.4.2 South America Clinical Next-Generation Sequencing Revenue by Countries/Regions 2014-2020
12.4.3 South America Clinical Next-Generation Sequencing Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Clinical Next-Generation Sequencing Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Clinical Next-Generation Sequencing Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Clinical Next-Generation Sequencing Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Clinical Next-Generation Sequencing Sales & Revenue Forecast 2021-2026
14.1 World Clinical Next-Generation Sequencing Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Clinical Next-Generation SequencingSales and Market Share by Regions
14.1.2 World Clinical Next-Generation SequencingRevenue and Market Share by Regions
15 Asia Clinical Next-Generation Sequencing Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Targeted Sequencing
15.1.2 Exome Sequencing
15.2 Consumption Forecast by Application, 2021-2026
16 North America Clinical Next-Generation Sequencing Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Targeted Sequencing
16.1.2 Exome Sequencing
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Clinical Next-Generation Sequencing Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Targeted Sequencing
17.1.2 Exome Sequencing
17.2 Consumption Forecast by Application, 2021-2026
18 South America Clinical Next-Generation Sequencing Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Targeted Sequencing
18.1.2 Exome Sequencing
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Clinical Next-Generation Sequencing Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Targeted Sequencing
19.1.2 Exome Sequencing
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Clinical Next-Generation Sequencing Price (USD/Unit) Trend 2021-2026
20.2 Global Clinical Next-Generation Sequencing Gross Profit Trend 2021-2026
21 Conclusion